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INTRODUCTION
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Candidate 
targets 
taken from 
the literature
Candidate targets for neuronal plasticity
Goal: Identify therapeutically relevant drug targets  to stimulate neuronal plasticity.
Similar cellular systems are regulated 
  by similar signaling pathways.
Candidate targets are identified from 
  the literature based on predetermined
  criteria (e.g. involvement in cell 
  migration and growth cone collapse)
Candidates
  Plasticity
(sprouting)
Consolidated / Non protrusive
Non consolidated / Protrusive
? Turning
growth cone
Neuron
Shaft vs. growth cone
Migrating
cell
Turning
growth cone
Migrating
cell
Candidate approach allows to identify new 
functions of known proteins, and therefore: 
Fast discovery of suitable targets,
Identify new uses for known drugs,
Minimize development risk (known drugs),
Maximize speed to market,
Fast track and orphan drug status (for many
  CNS indications).
Rationale and strategy:
Cell-based assay using  hippocampal neurons
Growing neurons are relatively plastic during development, which allows their neurites to 
  sprout and generate new connections.
Plasticity levels drop rapidly as neurons mature and become integrated into neuronal networks. 
As a consequence, the central nervous system ability to reorganize itself in response to injury 
  or disease is insufficient. 
One of the main limitations for the design of therapeutic strategies to enhance neurite 
  sprouting following neurological diseases is our poor understanding of the mechanisms 
  underlying neurite structural plasticity.
  Plasticity
Aging / Injury
Degeneration
  Toxicity
  Young cultured
neurons
  Aberrant
morphology
  Sprouting
  Neurons in vitro  
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Cell-based 
assays for: 
a) desired and 
b) undesired 
effects
Validation
steps:
a) Protein
expression
b) Protein 
Target               Drug          Doses      Efficiency
Inhibitor I
Inhibitor II
Inhibitor III
Inhibitor IV
Inhibitor V
Inhibitor VI
Inhibitor VII
10-100nM
1µM
10nM-1µM
5-10µM
1-50µM
25µM
15µM
10-25µM
-
+++
++/+++
++/+++
+++
++/+++
++
-
MT regulators
 
Actin regulator
Proteases
Health and neurite morphology
Actin assay Sprouting assay
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Validation I - Expression and activity
 Validation II - Participation in neurite sprouting
  Toxicity
  Young cultured
neurons
  Aberrant
morphology
MT regulator
 
Actin regulator
Healthy neurite
and growth 
cone
Case study:
Calpain
High dose
MT regulator
 
Calpain or
calpain activity
Not calpain or
no activity
      Calpain                        / /Calpain Tubulin ActinSince calpain is expected 
to act as a repressor of neurite 
sprouting, it must be expressed 
or active along the shaft, but 
not at growth cones.
  30-60min   treatment
  Control                           Treatment            
  Actin staining shows little 
accumulation along the
 neurite of control neurons
   
Appearance of patches is a 
sign of incipient sprouting
F-actin (pseudocolored)
Control
Treatment
  Intensity of actin
staining (yellow+red
area in pseudocolor)
obtained with some 
inhibitors of 
candidate proteins.
Folds of branches 
(- = no change)
obtained with 
some of the
inhibitors.
Examples of neurite morphology (actin staining).  
Experimental
set up
One day in vitro neurons:
- Fast (2 days) experiment  
- Actin staining in 20 mins 
- still very few branches
- great potential to branch
  
Good cell-assay for
inhibitors of potential 
targets.
   
Actin patches are required 
precursors of sprouts
Sick morphology.
Different inhibitors
of the same protein
are tested as well 
as lowed doses.
Well-defined growth
cone/shaft boundary
is characteristic of
healthy neurites. 
Because we focused on cytoskeleton
regulators, some interventions 
disorganize the structure of the neurite: 
Disruption of growth cone/shaft 
boundary
Disruption of actin cytoskeleton. 
Data from spinal cord injury research
shows delayed recovery in rats treated
with calpain inhibitors (potential proof
   of concept of sprouting)  
Pyramidal neurons
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(Proteolyzed Fodrin)
Calpain activity Actin
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Immunohistochemistry of calpain
in the hippocampus of adult mice
(CA1 field).
Calpain is expressed in 
neuronsin the mature brain 
and localizes to neurites.
Calpain is also expressed in immature neurons in vitro (image) and in vivo.
It preferentially localizes to consolidated (non protrusive) regions.
Calpain activity is restricted
to consolidated regions. No 
activity is detected at the
growth cone.
Fodrin is an endogenous
target of calpain. While
fodrin localizes to the entire
neuron, proteolysis (and
immunodetection) only
occurs where calpain is
active.
FluorochromeQuencher +
Calpain target
sequence
Free
fluorochrome
  Calpain reporter: t-Boc
Calpain 
t-Boc fluorescence
in primary neurons
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1. Sufficiency
2. Regulation by branching factors
3. Necessity for sprouting in response to br. factors
Genetic regulation
Overexpression of calpain
prevents branching. (Calpain 
overexpressing neurons have 
the same number of branches 
they had at 2div)
Branching  factors transiently inhibit calpain.
Calpain is inhibited during physiological neurite 
sprouting.
Endogenous calpain activity doesn't
seem to be required for normal neurite
morphology/functioning.
Calpain inhibitors are already being 
tested for CNS indications as 
neuroprotants.
Several calpain inhibition promote 
neurite sprouting.
Because of calpain role in neuronal
death, very specific inhibitors that 
cross the blood-brain-barrier are 
available.
Control                     Calpain     
CA1
CA3
dentate
gyrus
Cartoon of adult mice 
hippocampus.
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Pathway 
mapping
activity
c) Regulation
by branching
factors
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High levels of calpain can
be blocked with pharmacological
inhibitors. This inhibition induces
neurite sprouting.  
High levels of calpain cannot be blocked by
physiological inhibitors (branching factors).
Calpain inhibition is required for neurite 
sprouting. 
Pathway mapping to identify
additional targets.
1. Upstream / regulators
2. Downstream / effectors
Activation
by Ca  binding
2+
Balance of
phosphorylation
Potential regulators of calpain in neurons 
based in the literature (non-neuronal cells)  
Only the cAMP-PKA pathway is 
confirmed as maintaining calpain activation
in neurons (PKA acting as a repressor).
t-Boc fluorescence
Calpain
Cortactin    N-WASP   others
Actin patch formation
Potential downstream targets 
for calpain regulation of actin 
patch formation in neurons 
based in the literature 
(non-neuronal cells).  
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Loading
control 
Cortactin levels are
regulated by calpain
in neurons.
Cortactin accumulation
is restricted to areas of
low calpain activity.
t-Boc fluorescence
Control
Control      +cAMP      -PKA
-Calcium      -Erk
Red Fluo. Protein           Cortactin-RFP
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  30-60min   treatment
  24 hours
  Transfection
Sufficiency to promote sprouting
Necessity for sprouting in response 
to branching factors
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Elevation of cortactin levels
in the entire neuron is sufficient
to promote an hyperbranched
phenotype.
Inhibition of cortactin activity using a
dominant-negative construct prevents
neurite branching.
Approach:
                 Signaling convergency can be used as a starting point when previous
                 knowledge on the signaling pathways involved is missing.
     
        
Focusing on known proteins also allows faster mapping of the pathway upstream and 
downstream of the positive candidates (pathway validation vs. discovery), allowing the 
identification of additional, or  better, targets.
Focusing on known pathways minimizes the time to discovery of suitable 
targets because of the availability of reagents and (potentially) animal data. 
Experimental results:
Calpain
Calcium Erk
PKA
cAMP
                 Calpain maintains neurite consolidation by constitutively 
                 repressing protrusive activity. 
     
        
Neurite sprouting is a process of de-repression, as opposed 
to a "positive event".
                 Calpain and cortactin are two novel targets to stimulate  
                 neuronal morphological plasticity. 
     
        
                 The discovery of calpain function in neurons provides a link 
                 between cAMP levels and neuronal plasticity. 
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